APO Research
Talk to an analyst

APO RESEARCH · REPORT

Marek's Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Marek's Disease Vaccine Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchMarek's Disease Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Marek's Disease Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Marek's Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marek's Disease Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Marek's Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Marek's Disease Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marek's Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Marek's Disease Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Marek's Disease Vaccine market include Boehringer Ingelheim, Ceva, Merial, Zoetis, Beijing Huadu Shihua Biological Products Co., Ltd., Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Guangxi Lichengdong Biological Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Marek's Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Marek's Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Marek's Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marek's Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Marek's Disease Vaccine Segment by Company

Boehringer Ingelheim

Ceva

Merial

Zoetis

Beijing Huadu Shihua Biological Products Co., Ltd.

Guangdong Wen's Dahuanong Biotechnology Co., Ltd.

Guangxi Lichengdong Biological Co., Ltd.

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Merck

Ruipu Biopharmaceutical Co., Ltd.

Marek's Disease Vaccine Segment by Type

Bivalent Vaccine

Monovalent Vaccine

Marek's Disease Vaccine Segment by Application

Veterinary Pharmacy

Online Sale

Others

Marek's Disease Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Marek's Disease Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Marek's Disease Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Marek's Disease Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Marek's Disease Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marek's Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marek's Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marek's Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Marek's Disease Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marek's Disease Vaccine industry.

Chapter 3: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Marek's Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Marek's Disease Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Marek's Disease Vaccine Industry Trends Table 2. Marek's Disease Vaccine Industry Drivers Table 3. Marek's Disease Vaccine Industry Opportunities and Challenges Table 4. Marek's Disease Vaccine Industry Restraints Table 5. Global Marek's Disease Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Marek's Disease Vaccine Revenue Share by Company (2021-2026) Table 7. Global Marek's Disease Vaccine Sales Volume by Company (K Doses) & (2021-2026) Table 8. Global Marek's Disease Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Marek's Disease Vaccine Average Price (US$/Dose) of Company (2021-2026) Table 10. Global Marek's Disease Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Marek's Disease Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Marek's Disease Vaccine Company, Product Type & Application Table 13. Global Marek's Disease Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Marek's Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bivalent Vaccine Table 18. Significant Companies of Monovalent Vaccine Table 19. Global Marek's Disease Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Doses) Table 20. Global Marek's Disease Vaccine Sales Volume by Type (2021-2026) & (K Doses) Table 21. Global Marek's Disease Vaccine Sales Volume by Type (2027-2032) & (K Doses) Table 22. Global Marek's Disease Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Marek's Disease Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Marek's Disease Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Marek's Disease Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Marek's Disease Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Marek's Disease Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Marek's Disease Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Veterinary Pharmacy Table 30. Significant Companies of Online Sale Table 31. Significant Companies of Others Table 32. Global Marek's Disease Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Doses) Table 33. Global Marek's Disease Vaccine Sales Volume by Application (2021-2026) & (K Doses) Table 34. Global Marek's Disease Vaccine Sales Volume by Application (2027-2032) & (K Doses) Table 35. Global Marek's Disease Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Marek's Disease Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Marek's Disease Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Marek's Disease Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Marek's Disease Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Marek's Disease Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Marek's Disease Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Marek's Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 43. Global Marek's Disease Vaccine Sales by Region (2021-2026) & (K Doses) Table 44. Global Marek's Disease Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Marek's Disease Vaccine Sales by Region (2027-2032) & (K Doses) Table 46. Global Marek's Disease Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Marek's Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Marek's Disease Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Marek's Disease Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Marek's Disease Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Marek's Disease Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Marek's Disease Vaccine Market Average Price (US$/Dose) by Region (2021-2026) Table 53. Global Marek's Disease Vaccine Market Average Price (US$/Dose) by Region (2027-2032) Table 54. Global Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Table 55. Global Marek's Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Marek's Disease Vaccine Sales by Country (2021-2026) & (K Doses) Table 57. Global Marek's Disease Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Marek's Disease Vaccine Sales by Country (2027-2032) & (K Doses) Table 59. Global Marek's Disease Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Marek's Disease Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Marek's Disease Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Marek's Disease Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Marek's Disease Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Boehringer Ingelheim Company Information Table 65. Boehringer Ingelheim Business Overview Table 66. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 67. Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio Table 68. Boehringer Ingelheim Recent Development Table 69. Ceva Company Information Table 70. Ceva Business Overview Table 71. Ceva Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 72. Ceva Marek's Disease Vaccine Product Portfolio Table 73. Ceva Recent Development Table 74. Merial Company Information Table 75. Merial Business Overview Table 76. Merial Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 77. Merial Marek's Disease Vaccine Product Portfolio Table 78. Merial Recent Development Table 79. Zoetis Company Information Table 80. Zoetis Business Overview Table 81. Zoetis Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 82. Zoetis Marek's Disease Vaccine Product Portfolio Table 83. Zoetis Recent Development Table 84. Beijing Huadu Shihua Biological Products Co., Ltd. Company Information Table 85. Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview Table 86. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 87. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 88. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Development Table 89. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information Table 90. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview Table 91. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 92. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 93. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Development Table 94. Guangxi Lichengdong Biological Co., Ltd. Company Information Table 95. Guangxi Lichengdong Biological Co., Ltd. Business Overview Table 96. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 97. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 98. Guangxi Lichengdong Biological Co., Ltd. Recent Development Table 99. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information Table 100. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview Table 101. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 102. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 103. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Development Table 104. Merck Company Information Table 105. Merck Business Overview Table 106. Merck Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 107. Merck Marek's Disease Vaccine Product Portfolio Table 108. Merck Recent Development Table 109. Ruipu Biopharmaceutical Co., Ltd. Company Information Table 110. Ruipu Biopharmaceutical Co., Ltd. Business Overview Table 111. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 112. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio Table 113. Ruipu Biopharmaceutical Co., Ltd. Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Marek's Disease Vaccine Distributors List Table 117. Marek's Disease Vaccine Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Marek's Disease Vaccine Product Image Figure 2. Global Marek's Disease Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marek's Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Marek's Disease Vaccine Sales (2021-2032) & (K Doses) Figure 5. Global Marek's Disease Vaccine Sales Average Price (US$/Dose) & (2021-2032) Figure 6. Global Marek's Disease Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bivalent Vaccine Image Figure 10. Monovalent Vaccine Image Figure 11. Global Marek's Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 12. Global Marek's Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Marek's Disease Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Marek's Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Marek's Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Marek's Disease Vaccine Sales Value Share by Type (2021-2032) Figure 17. Veterinary Pharmacy Image Figure 18. Online Sale Image Figure 19. Others Image Figure 20. Global Marek's Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 21. Global Marek's Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Marek's Disease Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Marek's Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Marek's Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Marek's Disease Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Marek's Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 27. Global Marek's Disease Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Marek's Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Marek's Disease Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Marek's Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Marek's Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Marek's Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Marek's Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Marek's Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Marek's Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Marek's Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Marek's Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Marek's Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Marek's Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Marek's Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Marek's Disease Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Marek's Disease Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Bivalent Vaccine
  • Monovalent Vaccine
Applications
  • Veterinary Pharmacy
  • Online Sale
  • Others
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Merial
  • Zoetis
  • Beijing Huadu Shihua Biological Products Co., Ltd.
  • Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
  • Guangxi Lichengdong Biological Co., Ltd.
  • Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  • Merck
  • Ruipu Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Marek's Disease Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Marek's Disease Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Marek's Disease Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Marek's Disease Vaccine Market Dynamics
  1. 2.1 Marek's Disease Vaccine Industry Trends
  2. 2.2 Marek's Disease Vaccine Industry Drivers
  3. 2.3 Marek's Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Marek's Disease Vaccine Industry Restraints
3 Marek's Disease Vaccine Market by Company
  1. 3.1 Global Marek's Disease Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Marek's Disease Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Marek's Disease Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Marek's Disease Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Marek's Disease Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Marek's Disease Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Marek's Disease Vaccine Company Product Type and Application
  8. 3.8 Global Marek's Disease Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Marek's Disease Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Marek's Disease Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Marek's Disease Vaccine Market by Type
  1. 4.1 Marek's Disease Vaccine Type Introduction
  2. 4.1.1 Bivalent Vaccine
  3. 4.1.2 Monovalent Vaccine
  4. 4.2 Global Marek's Disease Vaccine Sales Volume by Type
  5. 4.2.1 Global Marek's Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Marek's Disease Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Marek's Disease Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Marek's Disease Vaccine Sales Value by Type
  9. 4.3.1 Global Marek's Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Marek's Disease Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Marek's Disease Vaccine Sales Value Share by Type (2021-2032)
5 Marek's Disease Vaccine Market by Application
  1. 5.1 Marek's Disease Vaccine Application Introduction
  2. 5.1.1 Veterinary Pharmacy
  3. 5.1.2 Online Sale
  4. 5.1.3 Others
  5. 5.2 Global Marek's Disease Vaccine Sales Volume by Application
  6. 5.2.1 Global Marek's Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Marek's Disease Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Marek's Disease Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Marek's Disease Vaccine Sales Value by Application
  10. 5.3.1 Global Marek's Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Marek's Disease Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Marek's Disease Vaccine Sales Value Share by Application (2021-2032)
6 Marek's Disease Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Marek's Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Marek's Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Marek's Disease Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Marek's Disease Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Marek's Disease Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Marek's Disease Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Marek's Disease Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Marek's Disease Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Marek's Disease Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Marek's Disease Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Marek's Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Marek's Disease Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Marek's Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Marek's Disease Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Marek's Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Marek's Disease Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Marek's Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Marek's Disease Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Marek's Disease Vaccine Sales Value Share by Country, 2025 VS 2032
7 Marek's Disease Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Marek's Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Marek's Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Marek's Disease Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Marek's Disease Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Marek's Disease Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Marek's Disease Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Marek's Disease Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Marek's Disease Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Marek's Disease Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Marek's Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Marek's Disease Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Marek's Disease Vaccine Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Merial
  14. 8.3.1 Merial Company Information
  15. 8.3.2 Merial Business Overview
  16. 8.3.3 Merial Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merial Marek's Disease Vaccine Product Portfolio
  18. 8.3.5 Merial Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Marek's Disease Vaccine Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
  25. 8.5 Beijing Huadu Shihua Biological Products Co., Ltd.
  26. 8.5.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
  27. 8.5.2 Beijing Huadu Shihua Biological Products Co., Ltd. Business Overview
  28. 8.5.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio
  30. 8.5.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
  31. 8.6 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
  32. 8.6.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
  33. 8.6.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Business Overview
  34. 8.6.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio
  36. 8.6.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
  37. 8.7 Guangxi Lichengdong Biological Co., Ltd.
  38. 8.7.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
  39. 8.7.2 Guangxi Lichengdong Biological Co., Ltd. Business Overview
  40. 8.7.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio
  42. 8.7.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments
  43. 8.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
  44. 8.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
  45. 8.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
  46. 8.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio
  48. 8.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Marek's Disease Vaccine Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Ruipu Biopharmaceutical Co., Ltd.
  56. 8.10.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio
  60. 8.10.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Marek's Disease Vaccine Value Chain Analysis
  2. 9.1.1 Marek's Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Marek's Disease Vaccine Sales Mode & Process
  6. 9.2 Marek's Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Marek's Disease Vaccine Distributors
  9. 9.2.3 Marek's Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst